Cargando…
Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation
BACKGROUND: Visceral leishmaniasis is the most severe form of leishmaniasis and no effective vaccine exists. The use of live attenuated vaccines is emerging as a promising vaccination strategy. RESULTS: In this study, we tested the ability of a Leishmania infantum deletion mutant, lacking both HSP70...
Autores principales: | Carrión, Javier, Folgueira, Cristina, Soto, Manuel, Fresno, Manuel, Requena, Jose M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199857/ https://www.ncbi.nlm.nih.gov/pubmed/21794145 http://dx.doi.org/10.1186/1756-3305-4-150 |
Ejemplares similares
-
Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice
por: Solana, José Carlos, et al.
Publicado: (2020) -
Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models
por: Solana, José Carlos, et al.
Publicado: (2017) -
Inoculation of the Leishmania infantum HSP70-II Null Mutant Induces Long-Term Protection against L. amazonensis Infection in BALB/c Mice
por: Soto, Manuel, et al.
Publicado: (2021) -
The Leishmania infantum PUF proteins are targets of the humoral response during visceral leishmaniasis
por: Folgueira, Cristina, et al.
Publicado: (2010) -
The expression of HSP83 genes in Leishmania infantum is affected by temperature and by stage-differentiation and is regulated at the levels of mRNA stability and translation
por: Larreta, Ruth, et al.
Publicado: (2004)